Chai Discovery
Chai Discovery is building a world where new medicines are not found through trial and error, but designed with the precision, speed and scale of modern engineering. Chai’s models reason about biological structure and function, generate new molecular designs from scratch, and help pharma teams pursue targets traditional discovery methods struggle to reach. Founded in 2024, based in San Francisco and backed by leading investors, Chai’s partners include Eli Lilly and Pfizer.
